CHICAGO, Illinois, Feb. 6 -- McDermott Will and Emery, a law firm, issued the following news release:

McDermott Will & Emery advised Lauxera Capital Partners on its investment in Acandis, a leading German neurovascular medical device company dedicated to the prevention and treatment of stroke.

Lauxera Capital Partners' Acandis transaction is the firm's first investment out of Lauxera Growth II, its second-generation healthcare growth buyout fund.